LUMO

Lumos Pharma, Inc.

2.95 USD
-0.07 (-2.32%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Lumos Pharma, Inc. stock is up 5.73% since 30 days ago. The next earnings date is Mar 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 46.15% of the previous 12 February’s closed higher than January.

About Lumos Pharma, Inc.

Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren.